Your patient with melanoma: staging, prognosis, and treatment
- PMID: 19860037
Your patient with melanoma: staging, prognosis, and treatment
Abstract
Melanoma, a cancer of melanocytes, pigment-producing cells in the skin, is the most serious form of skin cancer. Its incidence is increasing rapidly and reaching epidemic proportions. When detected early, it is considered curable, but when detected at later stages it is arguably one of the most lethal malignancies and is the cause of more years of lost life than any other cancer except leukemia. Because most cutaneous melanomas are visible, however, melanoma in general is a cancer highly amenable to early detection. Surgery is standard treatment for localized melanoma. There is no standard therapy for advanced-stage melanoma. Metastatic melanoma disseminates widely and it frequently involves sites that are not commonly affected in other cancers, such as the gastrointestinal tract and skin. The median survival time for patients with metastatic melanoma is less than 1 year. Despite these grim statistics, long-term survival occurs occasionally. This article will review diagnosis, staging, and treatment for malignant melanoma and will discuss the nursing role in the care of patients with melanoma.
Comment in
-
Melanoma: an under-recognized cancer threat.Oncology (Williston Park). 2009 Jul;23(8 Suppl):22. Oncology (Williston Park). 2009. PMID: 19860038 No abstract available.
Similar articles
-
[Melanoma].Rev Prat. 1999 Apr 15;49(8):833-7. Rev Prat. 1999. PMID: 10337195 Review. French.
-
Nursing the patient with malignant melanoma: early intervention.Br J Nurs. 2009 Mar 12-25;18(5):288, 290-2. doi: 10.12968/bjon.2009.18.5.40541. Br J Nurs. 2009. PMID: 19273989 Review.
-
Malignant melanoma: an update on treatments.Plast Surg Nurs. 1999 Fall;19(3):143-7. Plast Surg Nurs. 1999. PMID: 10765299 Review.
-
[The latest diagnostical methods and therapy in melanoma].Przegl Lek. 2006;63(8):674-80. Przegl Lek. 2006. PMID: 17441381 Review. Polish.
-
Malignant melanoma: management guidelines.Geriatrics. 1990 Jun;45(6):55-8, 61-2. Geriatrics. 1990. PMID: 2187751 Review.
Cited by
-
Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse's perspective.Support Care Cancer. 2012 Aug;20(8):1601-11. doi: 10.1007/s00520-012-1473-0. Epub 2012 May 5. Support Care Cancer. 2012. PMID: 22562583 Review.
-
Enhanced anti-melanoma efficacy of interferon α-2b via overexpression of ING4 by enhanced Fas/FasL-mediated apoptosis.Oncol Lett. 2018 Jun;15(6):9577-9583. doi: 10.3892/ol.2018.8534. Epub 2018 Apr 18. Oncol Lett. 2018. PMID: 29805679 Free PMC article.
-
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.Carcinogenesis. 2012 Oct;33(10):1823-32. doi: 10.1093/carcin/bgs205. Epub 2012 Jun 12. Carcinogenesis. 2012. PMID: 22693259 Free PMC article. Review.
-
Mediastinal and hilar sarcoid-like reaction in a patient treated with dabrafenib and trametinib for metastatic melanoma: A case report and review of the literature.Mol Clin Oncol. 2022 May;16(5):99. doi: 10.3892/mco.2022.2532. Epub 2022 Mar 18. Mol Clin Oncol. 2022. PMID: 35400120 Free PMC article.
-
Integrative analysis of competing endogenous RNA network focusing on long noncoding RNA associated with progression of cutaneous melanoma.Cancer Med. 2018 Apr;7(4):1019-1029. doi: 10.1002/cam4.1315. Epub 2018 Mar 9. Cancer Med. 2018. PMID: 29522273 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical